Ironwood Investment Counsel LLC Lowers Position in The Clorox Company $CLX

Ironwood Investment Counsel LLC decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 7.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,447 shares of the company’s stock after selling 537 shares during the period. Ironwood Investment Counsel LLC’s holdings in Clorox were worth $774,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CLX. Vanguard Group Inc. boosted its position in shares of Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock valued at $2,293,135,000 after acquiring an additional 65,924 shares during the last quarter. Northern Trust Corp increased its position in shares of Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after purchasing an additional 34,655 shares during the last quarter. Invesco Ltd. raised its stake in Clorox by 7.4% in the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock valued at $200,512,000 after purchasing an additional 94,371 shares in the last quarter. ProShare Advisors LLC lifted its position in Clorox by 7.0% during the second quarter. ProShare Advisors LLC now owns 1,160,881 shares of the company’s stock valued at $139,387,000 after purchasing an additional 75,514 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after purchasing an additional 41,485 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Activity at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 0.3%

Shares of CLX opened at $104.99 on Wednesday. The stock has a market capitalization of $12.81 billion, a P/E ratio of 16.10, a PEG ratio of 0.92 and a beta of 0.52. The Clorox Company has a twelve month low of $104.08 and a twelve month high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The firm has a fifty day simple moving average of $118.92 and a two-hundred day simple moving average of $124.26.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the prior year, the company posted $1.86 EPS. Clorox’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date was Wednesday, October 22nd. Clorox’s payout ratio is 77.86%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CLX. Citigroup decreased their price target on shares of Clorox from $130.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. Wells Fargo & Company reduced their target price on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Rothschild & Co Redburn dropped their price target on Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a report on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $125.69.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.